Advanced Search

 

Study ID Status Title Patient Level Data
207759 Recruiting An observer-blind study to evaluate the safety, reactogenicity and immunogenicity of the investigational GSK Biologicals’ COPD vaccine (GSK3277511A) in adults
207781 Completed Post-authorisation passive enhanced safety surveillance of seasonal influenza vaccines: Pilot study in England 2017/18
207782 Completed A Clinical Study to Assess the Cutaneous and Ocular Local Tolerance of Two Cosmetic Facial Cleansers in Healthy Females with Sensitive Skin Under Normal Conditions of Use
207804 Not yet recruiting A two-part phase I randomized double blind (sponsor open) placebo controlled study to evaluate safety, tolerability, pharmacokinetics, target engagement and potential for efficacy of single intravenous and subcutaneous doses of GSK3858279 in healthy volunteers and participants with osteoarthritis of the knee
207814 Completed The comparative efficacy, safety and tolerability of herpes zoster vaccines
207872 Completed A Proof of Principal Study to Investigate the Stain Control of Two Stannous Fluoride Dentifrices
207877 Recruiting Meta-Analysis to evaluate the impact of exacerbations on Health-Related Quality of Life, FEV1, risk of further exacerbations, and mortality using data from GSK COPD observational studies and those for Fluticasone Propionate, Salmeterol/Fluticasone Propionate, Fluticasone Furoate/Vilanterol, and mepolizumab
207878 Completed Efficacy and Safety of Belimumab in a Subgroup of Systemic Lupus Erythematosus (SLE) Patients with High Disease Activity (anti-dsDNA positive and low complement and SELENA-SLEDAI score >=10): A Pooled Analysis of the HGS1006-C1056 (BLISS-76) and HGS1006-C1057 (BLISS-52) Studies
207891 Not yet recruiting PGx7682 Exploratory Genetic Analysis for GSK2894512 for efficacy in atopic dermatitis patients in 203121
207911 Recruiting A sourcing study to collect human biological (serum) samples from healthy adults
207926 Not yet recruiting PGx7680 Exploratory Meta-analysis of METRO (metformin response) and MetGen (Metformin response consortium)
207927 Completed PGx7683_Exploratory PGx analysis for GSK1325760 (Ambrisentan) in 112565
207933 Active, not recruiting PGx7684: Confirmatory pharmacogenetic study investigating IL13 association with efficacy response to fluticasone furoate/vilanterol in asthma study 201378
207935 Not yet recruiting PGx7685:Exploratory PGx evaluation of adverse events observed in subjects treated with GSK3342830 in 204847 Part 2
207941 Not yet recruiting Meta-Analysis Plan for MID207941: A Study to Evaluate Risk Factors for Pneumonia and Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in a COPD Population of Patients Treated with GW685698 + GW642444 (Fluticasone Furoate + Vilanterol); GW642444 (Vilanterol); CCI18781 (Fluticasone Propionate); GR33343 (Salmeterol); CCI18781+ GR33343 (Fluticasone Propionate + Salmeterol) and Placebo
207943 Not yet recruiting Observational and retrospective study to collect long term follow-up real life data from the first patients treated by Nucala in France in the context of nATU
207968 Not yet recruiting Comparative Effectiveness of Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol
207969 Not yet recruiting Comparative Effectiveness of Umeclidinium/Vilanterol versus ICS/LABA Therapy
207972 Recruiting A double blind (sponsor open) placebo-controlled, stratified, parallel group study to evaluate the efficacy and safety of repeat doses of GSK3772847 in participants with moderate to severe asthma with allergic fungal airway disease (AFAD)
208034 Recruiting Understanding of the Patient and Caregiver Experience of Wiskott-Aldrich Syndrome (WAS)
208059 Not yet recruiting Population Pharmacokinetic Modeling of Fluticasone Furoate, Umeclidinium bromide and Vilanterol using Pooled Data from three Phase III (Fluticasone Furoate/Umeclidinium bromide/Vilanterol) studies (200812, CTT116853 and CTT116855) in adults with Chronic Pulmonary Obstructive Disease
208078 Completed A Randomized, Examiner-blind, Proof of Principal Study to Investigate the Stain and Plaque Removal Capability of Two Experimental 5% Potassium Nitrate Dentifrices in Healthy Subjects with the Propensity for Extrinsic Dental Stain
208091 Not yet recruiting Meta-analysis of studies MEA115588 and 200862 of mepolizumab (SB240563) to evaluate changes in AM PEF in severe eosinophilic asthma (eTrack Study Identifier 208091)
208099 Not yet recruiting PGx7687: Exploratory Pharmacogenetic Study to Investigate Efficacy of SB252263 Tafenoquine on relapse of P Vivax Malaria in TAF112582 and TAF115654
208108/091 Completed A phase II, double-blind, randomized study to compare the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ Tritanrix™-HepB/Hib2.5 to GSK Biologicals’ Tritanrix™-HepB/Hiberix™ when administered as a three-dose primary vaccination course to healthy infants at 6, 10 and 14 weeks of age. A dose of unconjugated Hib vaccine (plain PRP booster) will be administered at the age of 10 months to 50% of the subjects Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.